3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
6
Thoracic
2
Genitourinary
2
Breast
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Endocrine
1
Dermatologic
1
Conditions
Ovarian Neoplasms
51
Endometrial Neoplasms
21
Fallopian Tube Neoplasms
17
Sarcoma
9
Peritoneal Neoplasms
9
Neoplasm Metastasis
7
Neoplasms
6
Liposarcoma
6
Leiomyosarcoma
5
Hemangiosarcoma
5
Fibrosarcoma
5
Carcinoma, Ovarian Epithelial
5
Uterine Neoplasms
4
Stomach Neoplasms
4
Sarcoma, Synovial
4
Recurrence
4
Neurofibrosarcoma
4
Malignant mesenchymal tumor
4
Histiocytoma, Malignant Fibrous
4
Desmoplastic Small Round Cell Tumor
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma, Endometrial Stromal
3
Rhabdomyosarcoma
3
Hemangiopericytoma, Malignant
3
Breast Neoplasms
3
Appendiceal Neoplasms
3
Sarcoma, Alveolar Soft Part
2
Pheochromocytoma
2
Interventions
pembrolizumab
8
Oxaliplatin
7
Surveys and Questionnaires
5
Methods
5
Early Intervention, Educational
5
Cyclophosphamide
5
Cisplatin
5
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Gemcitabine
4
Fluorouracil
4
Carboplatin
4
veliparib
3
aldesleukin
3
Trastuzumab
3
Specimen Handling
3
Nivolumab
3
Diathermy
3
Cytoreduction Surgical Procedures
3
sargramostim
2
entinostat
2
cemiplimab
2
cediranib
2
X-Rays
2
Therapeutics
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Metformin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Doxorubicin
×
Gynecologic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled